|
|
Article: LaVoie Group Selected by Vaccine Developer, Profectus BioSciences, as Agency of Record.
- Article from:
- PR Newswire
- Article date:
- April 29, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SALEM, Mass., April 29 /PRNewswire/ -- LaVoie Group, a life science-focused strategic communications agency, announced today that it has been selected as public relations agency of record by therapeutic vaccine development company, Profectus BioSciences, Inc.
Donna L. LaVoie, President & CEO of LaVoie Group, commented, "We are delighted to represent Profectus during an important stage in the company's clinical development. We look forward to working with them to communicate their message to appropriate investors, media, pharmaceutical partners and physicians."
Shawn Patrick O'Brien, Chief Executive Officer, commented, "Profectus BioSciences has a ...
Related newspaper, magazine, and journal articles:
|
|
Article: Profectus BioSciences Enters into Research ...
Business Wire;
August 25, 2009 ;
700+ words
...BALTIMORE -- Profectus BioSciences, Inc. (Profectus ... Chief Executive Officer of Profectus BioSciences, commented, "We consider ... vaccine candidate." About Profectus BioSciences Vaccine Platforms Profectus ...
|
|